These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 422287)

  • 21. Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor.
    Morgan K; Clague RB; Shaw MJ; Firth SA; Twose TM; Holt PJ
    Arthritis Rheum; 1981 Nov; 24(11):1356-62. PubMed ID: 7317113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly cytotoxic antisera obtained in W/Fu rats against a syngeneic Gross virus induced lymphoma.
    Gerlier D; Guibout C; Dore JF
    Eur J Cancer (1965); 1977 Aug; 13(8):855-9. PubMed ID: 908347
    [No Abstract]   [Full Text] [Related]  

  • 23. Decomplementation with cobra venom factor prolongs survival of xenografted islets in a rat to mouse model.
    Oberholzer J; Yu D; Triponez F; Cretin N; Andereggen E; Mentha G; White D; Buehler L; Morel P; Lou J
    Immunology; 1999 May; 97(1):173-80. PubMed ID: 10447729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of an automatic cell harvester in a cellular radioimmunoassay.
    Gerlier D; Avice T
    J Immunol Methods; 1984 Dec; 75(1):159-66. PubMed ID: 6512263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma.
    Nunn ME; Djeu JY; Glaser M; Lavrin DH; Herberman RB
    J Natl Cancer Inst; 1976 Feb; 56(2):393-9. PubMed ID: 1082939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma.
    Ioachim HL; Keller SE; Dorsett BH; Pearse A
    J Exp Med; 1974 Jun; 139(6):1382-94. PubMed ID: 4208416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of immunoregulatory alpha-globulin on in vitro proliferative response of immune rat lymphocytes to syngeneic Gross virus-induced lymphoma.
    Glaser M; Herberman RB
    J Natl Cancer Inst; 1974 Dec; 53(6):1767-9. PubMed ID: 4140239
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of cobra venom factor treatment on latent feline leukemia virus infection.
    Kraut EH; Rojko JL; Olsen RG; Tuomari DL
    J Virol; 1985 Jun; 54(3):873-5. PubMed ID: 2987539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse system.
    Van den Berg CW; Aerts PC; Van Dijk H
    J Immunol Methods; 1990 Oct; 133(2):199-206. PubMed ID: 2230138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
    Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
    Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of immune complexes in serum by adsorption on staphylococcal protein A: model studies and application to sera of rats bearing a gross virus-induced lymphoma.
    Tucker DF; Begent RH; Hogg NM
    J Immunol; 1978 Nov; 121(5):1644-51. PubMed ID: 712061
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulation of delayed hypersensitivity in mice by cobra venom factor.
    Bloksma N; van Dijk H; Bijlsma W; Willers J
    Cell Immunol; 1979 Aug; 46(1):187-91. PubMed ID: 487442
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on type II collagen induced polyarthritis in rats. Effect of complement depletion.
    Kerwar SS; Bauman N; Oronsky AL; Sloboda AE
    J Immunopharmacol; 1981-1982; 3(3-4):323-37. PubMed ID: 7347767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis in rats.
    Gaede KI; Baumeister E; Heesemann J
    Infect Immun; 1995 Sep; 63(9):3697-701. PubMed ID: 7642308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of viral and cell-associated antigens in the cell-mediated immune response of rats to virus-induced lymphoma cells.
    Bernstein ID; Nowinski RC; Stiefel J
    J Immunol; 1980 Apr; 124(4):1727-32. PubMed ID: 6965959
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of effect of short-term depletion of plasma complement C3 on the survival of syngeneic dopaminergic neurons following grafting into the intact rat striatum.
    Khorooshi MH; Meyer M; Pedersen EB; Finsen B
    Cell Transplant; 1999; 8(5):489-99. PubMed ID: 10580343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje.
    Van den Berg CW; Aerts PC; Van Dijk H
    J Immunol Methods; 1991 Feb; 136(2):287-94. PubMed ID: 1999656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of decomplementation on the infectious course of Sendai virus in mice.
    Finnie JC; Aston WP; O'Shaughnessy MV; Stewart RB
    Can J Microbiol; 1982 May; 28(5):474-7. PubMed ID: 6286080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged complement activation in mice.
    Simpson IJ; Moran J; Evans DJ; Peters DK
    Kidney Int; 1978 Jun; 13(6):467-71. PubMed ID: 713282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.
    Usami M; Ohno Y
    J Pharmacol Toxicol Methods; 2005; 52(2):260-3. PubMed ID: 16125624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.